Abstract
Genetic risk prediction models such as BRCAPRO are used routinely in genetic counseling for identification of potential BRCA1 and BRCA2 mutation carriers. They require extensive information on the counselee and her family history, and thus are not practical for primary care. To address this gap, we develop and test a two-stage approach to genetic risk assessment by balancing the tradeoff between the amount of information used and accuracy achieved. The first stage is intended for primary care wherein limited information is collected and analyzed using a simplified version of BRCAPRO. If the assessed risk is sufficiently high, more extensive information is collected and the full BRCAPRO is used (stage two: intended for genetic counseling). We consider three first-stage tools: BRCAPROLYTE, BRCAPROLYTE-Plus, and BRCAPROLYTE-Simple. We evaluate the two-stage approach on independent clinical data on probands with family history of breast and ovarian cancers, and BRCA genetic test results. These include population-based data on 1344 probands from Newton-Wellesley Hospital and mostly high-risk family data on 2713 probands from Cancer Genetics Network and MD Anderson Cancer Center. We use discrimination and calibration measures, approp...Continue Reading
References
May 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Mar 7, 1998·American Journal of Human Genetics·G ParmigianiO Aguilar
Nov 15, 2000·Clinical Genetics·C A GilpinA G Hunter
Apr 5, 2003·American Journal of Human Genetics·A AntoniouD F Easton
Oct 25, 2003·Science·Mary-Claire KingUNKNOWN New York Breast Cancer Study Group
May 2, 2006·Statistical Applications in Genetics and Molecular Biology·Sining ChenGiovanni Parmigiani
Sep 28, 2006·JAMA : the Journal of the American Medical Association·Sining ChenUNKNOWN Colon Cancer Family Registry
Mar 24, 2007·BMC Medical Genetics·Hormuzd A Katki
Apr 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wenyi WangAlison P Klein
Oct 3, 2007·Annals of Internal Medicine·Giovanni ParmigianiDavid M Euhus
Apr 15, 2008·Statistics in Medicine·Hormuzd A KatkiGiovanni Parmigiani
May 10, 2008·Breast Cancer Research : BCR·Yu Chuan TaiAlison P Klein
Dec 17, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sining ChenGiovanni Parmigiani
Mar 19, 2009·The Breast Journal·Elissa M OzanneKevin S Hughes
Sep 25, 2009·The Breast Journal·Brian DrohanKevin S Hughes
Jan 14, 2010·Cancer Research·Wenyi WangHensin Tsao
Jan 25, 2012·Breast Cancer Research and Treatment·Swati BiswasBanu Arun
Mar 20, 2012·Annals of Surgical Oncology·Brian DrohanKevin S Hughes
May 22, 2013·Breast Cancer Research and Treatment·Swati BiswasGiovanni Parmigiani
May 3, 2015·Gynecologic Oncology·Terri FebbraroAshley Stuckey
May 20, 2015·Cancer Informatics·Emanuele MazzolaSwati Biswas
Citations
Mar 8, 2018·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Katie StollStephanie A Cohen
Jun 27, 2018·Genetic Epidemiology·Thomas MadsenLorenzo Trippa
Jul 7, 2018·The American Journal of Surgical Pathology·Shoko VosPaul J van Diest
Dec 5, 2018·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Flore LaforestAdrian Edwards
Aug 21, 2019·JAMA : the Journal of the American Medical Association·UNKNOWN US Preventive Services Task ForceJohn B Wong
Aug 29, 2020·Expert Review of Molecular Diagnostics·Sonya ReidTuya Pal
Jul 18, 2020·JNCI Cancer Spectrum·Jinbo ChenTimothy R Rebbeck
Aug 21, 2019·JAMA : the Journal of the American Medical Association·Heidi D NelsonRebecca Holmes
Sep 26, 2020·Nature Reviews. Clinical Oncology·Ophira GinsburgPaul Brennan